BrainCheck Care™ empowers physicians to deliver advanced cognitive healthcare at scale, a much needed win for dementia patients and caregivers
As digital medicine continues to transform patient care, we announced the launch of BrainCheck Care, a digital, reimbursable cognitive care management technology, at the 2018 Alzheimer’s Association International Conference in Chicago.
This end-to-end solution is the first of its kind and allows physicians to deliver personalized recommendations to help improve outcomes and prolong independence for people living with dementia and cognitive impairment. With the addition of BrainCheck Care to our cognitive testing platform, physicians now have a full suite of tools to help assess and effectively manage cognitive impairment, facilitating meaningful conversations with patients and their caregivers.
The digital platform incorporates a wide range of screening tools and streamlined workflows to collect patient and caregiver inputs. By combining these disparate components with its clinical decision support algorithms, BrainCheck Care helps the physician provide a treatment plan that is tailored to the patient’s needs.
Dementia has no cure, but the benefits of early detection have become increasingly compelling, leading to new clinical practice guidelines, new reimbursement codes for cognitive care management and a new initiative by the Alzheimer’s Association to help doctors take a leading role in dementia care.
BrainCheck Care comes on the heels of these changes, providing technology to make it easy for physicians to adhere to the updated guideline, and take advantage of the new reimbursement code and cost savings associated with cognitive care management.
To celebrate the release of BrainCheck Care, we hosted a special launch event on Monday, July 23, 2018, at the Marriott Marquis Chicago. BrainCheck co-founder and New York Times bestselling author, Dr. David Eagleman, along with a panel of industry experts, discussed the benefits of providing care planning services to cognitively impaired individuals.
View the full press release here.
